Biomedical Engineering Reference
In-Depth Information
(2003) Common structure of soluble amyloid
oligomers implies common mechanism of
pathogenesis. Science 300:486-489
4. Cecchi C, Baglioni S, Fiorillo C, Pensalfini A,
Liguri G, Nosi D, Rigacci S, Bucciantini M,
Stefani M (2005) Insights into the molecular
basis of the differing susceptibility of varying
cell types to the toxicity of amyloid aggre-
gates. J Cell Sci 118:3459-3470
5. Kourie JI, Henry CL (2002) Ion channel for-
mation and membrane-linked pathologies of
misfolded hydrophobic proteins: the role of
dangerous unchaperoned molecules. Clin Exp
Pharmacol Physiol 29:741-753
6. Kayed R, Sokolov Y, Edmonds B, McIntire
TM, Milton SC, Hall JE, Glabe CG (2004)
Permeabilization of lipid bilayers is a common
conformation-dependent activity of soluble
amyloid oligomers in protein misfolding dis-
eases. J Biol Chem 279:46363-46366
7. Cecchi C, Nichino D, Zampagni M,
Bernacchioni C, Evangelisti E, Liguri G,
Pensalfini A, Gliozzi A, Stefani M, Relini A
(2009) A protective role for lipid raft choles-
terol against amyloid-induced membrane
damage
13. Diociaiuti M, Polzi LZ, Valvo L, Malchiodi-
Albedi F, Bombelli C, Gaudiano MC (2006)
Calcitonin forms oligomeric pore-like structures
in lipid membranes. Biophys J 91:2275-2281
14. Engel MFM, Khemtemourian L, Kleijer CC,
Meeldijk HJD, Jacobs J, Verkleij AJ, de Kruijff
B, Killian JA, Hoppener JWM (2008)
Membrane damage by human islet amyloid
polypeptide through fibril growth at the
membrane. PNAS 105:6033-6038
15. Pieri L, Bucciantini M, Guasti P, Savistchenk J,
Melki R, Stefani M (2009) Synthetic lipid ves-
icles recruit native-like aggregates and affect
the aggregation process of the prion Ure2p:
insights on vesicles permeabilization and
charge selectivity. Biophis J 96:3319-3330
16. Selkoe DJ (2001) Alzheimer's disease: genes,
proteins, and therapy. PhysiolRev 81:741-766
17. Dahlgren KN, Manelli AM, Stine WB, Baker
LK, Krafft GA, LaDu MJ (2002) Oligomeric
and fibrillar species of amyloid-b peptides dif-
ferentially affect neuronal viability. J Biol
Chem 277:32046-32053
18. Klein WL (2002) Ab toxicity in Alzheimer's
disease: globular oligomers (ADDLs) as new
vaccine and drug targets. Neurochem Intl
41:345-352
19. Lacor PN, Buniel MC, Chang L, Fernandez
SJ, Gong Y, Viola KL, Lambert MP, Velasco
PT, Bigio EH, Finch CE, Krafft GA, Klein WI
(2004) Synaptic targeting by Alzheimer's-
related amyloid b oligomers. J Neurosci
24:10191-10200
20. Wakabayashi M, Okada T, Kozutsumi Y,
Matsuzaki K (2005) GM1 ganglioside-medi-
ated accumulation of amyloid beta-protein on
cell membranes. Biochim Biophys Res Com
328:1019-1023
21. Demuro A, Mina E, Kayed R, Milton S, Parker
I, Glabe CG (2005) Calcium dysregulation
and membrane disruption as a ubiquitous
neurotoxic mechanism of soluble amyloid oli-
gomers. J Biol Chem 280:17294-17300
22. Kayed R, Pensalfini A, Margol L, Sokolov Y,
Sarsoza F, Head E, Hall J, Glabe CG (2009)
Annular protofibrils are a structurally and
functionally distinct type of amyloid oligomer.
J Biol Chem 284:4230-4237
in
human
neuroblastoma
cells.
Biochim Biophys Acta 1788:2204-2216
8. Gosal WS, Meyers SL, Radford SE, Thomson
NH (2006) Amyloid under the atomic force
microscope. Protein Pept Lett 13:261-270
9. Santos NC, Castanho MA (2004) An over-
wiew of the biophysical applications of atomic
force microscopy. Biophys Chem 2:133-149
10. Möller C, Allen M, Elings V, Engel A, Müller
DJ (1999) Tapping-mode atomic microscopy
produces faithful high-resolution images of
protein surfaces. Biophys J 77:1150-1158
11. Müller DJ, Fotiadis D, Scheurig S, Müller SA,
Engel A (1999) Electrostatically balanced
subnanometer imaging of biological speci-
mens by atomic force microscopy. Biophys J
76:1101-1111
12. Tashima Y, Oe R, Lee S, Sugihara G (2004)
The effect of cholesterol and monosialogan-
glioside (GM1) on the release and aggrega-
tion of amyloid beta-peptide from liposomes
prepared from brain membrane-like lipids.
J Biol Chem 279:17587-17595
Search WWH ::
Custom Search